These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33237817)

  • 1. Factors Related to Improvement of Glycemic Control Among Adults with Type 1 Diabetes During Lockdown Due to COVID-19.
    Moreno-Domínguez Ó; González-Pérez de Villar N; Barquiel B; Hillman-Gadea N; Gaspar-Lafuente R; Arévalo-Gómez M; Herranz L
    Diabetes Technol Ther; 2021 May; 23(5):399-400. PubMed ID: 33237817
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycemic Control of Patients with Type 1 Diabetes Using an Insulin Pump Before and During the COVID-19-Associated Quarantine.
    Barmpagianni A; Lambadiari V; Papazafiropoulou A; Kountouri A; Stergiou A; Melidonis A; Liatis S
    Diabetes Technol Ther; 2021 Apr; 23(4):320-321. PubMed ID: 33232615
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump.
    Viñals C; Mesa A; Roca D; Vidal M; Pueyo I; Conget I; Giménez M
    Acta Diabetol; 2021 Mar; 58(3):383-388. PubMed ID: 33125525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic control in type 1 diabetes mellitus and COVID-19 lockdown: What comes after a "quarantine"?
    Ceconi V; Barbi E; Tornese G
    J Diabetes; 2020 Dec; 12(12):946-948. PubMed ID: 32909344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study.
    Wu X; Luo S; Zheng X; Ding Y; Wang S; Ling P; Yue T; Xu W; Yan J; Weng J
    J Diabetes Investig; 2021 Sep; 12(9):1708-1717. PubMed ID: 33539665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
    Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
    Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020.
    Nwosu BU; Al-Halbouni L; Parajuli S; Jasmin G; Zitek-Morrison E; Barton BA
    Front Endocrinol (Lausanne); 2021; 12():703905. PubMed ID: 34447352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity.
    Tornese G; Ceconi V; Monasta L; Carletti C; Faleschini E; Barbi E
    Diabetes Technol Ther; 2020 Jun; 22(6):462-467. PubMed ID: 32421355
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 and diabetes mellitus. Importance of glycemic control.
    Alonso N; Batule S
    Clin Investig Arterioscler; 2021; 33(3):148-150. PubMed ID: 34074468
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.
    Alharthi SK; Alyusuf EY; Alguwaihes AM; Alfadda A; Al-Sofiani ME
    Diabetes Res Clin Pract; 2021 Mar; 173():108682. PubMed ID: 33539868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic.
    Tao J; Gao L; Liu Q; Dong K; Huang J; Peng X; Yang Y; Wang H; Yu X
    Diabetes Res Clin Pract; 2020 Dec; 170():108514. PubMed ID: 33068663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown.
    Boscari F; Ferretto S; Uliana A; Avogaro A; Bruttomesso D
    Nutr Diabetes; 2021 Jan; 11(1):1. PubMed ID: 33414391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.
    Predieri B; Leo F; Candia F; Lucaccioni L; Madeo SF; Pugliese M; Vivaccia V; Bruzzi P; Iughetti L
    Front Endocrinol (Lausanne); 2020; 11():595735. PubMed ID: 33424771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
    Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
    Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of diabetes home control in COVID-19 times: Proof is in the pudding.
    Cotovad-Bellas L; Tejera-Pérez C; Prieto-Tenreiro A; Sánchez-Bao A; Bellido-Guerrero D
    Diabetes Res Clin Pract; 2020 Oct; 168():108379. PubMed ID: 32853692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic.
    Ruissen MM; Regeer H; Landstra CP; Schroijen M; Jazet I; Nijhoff MF; Pijl H; Ballieux BEPB; Dekkers O; Huisman SD; de Koning EJP
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33431602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caring for a child with type 1 diabetes during COVID-19 lockdown in a developing country: Challenges and parents' perspectives on the use of telemedicine.
    Odeh R; Gharaibeh L; Daher A; Kussad S; Alassaf A
    Diabetes Res Clin Pract; 2020 Oct; 168():108393. PubMed ID: 32858098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown.
    Anjana RM; Pradeepa R; Deepa M; Jebarani S; Venkatesan U; Parvathi SJ; Balasubramanyam M; Radha V; Poongothai S; Sudha V; Shanthi Rani CS; Ranjani H; Amutha A; Manickam N; Unnikrishnan R; Mohan V
    Diabetes Technol Ther; 2020 Jul; 22(7):527-534. PubMed ID: 32522031
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring.
    Dover AR; Ritchie SA; McKnight JA; Strachan MWJ; Zammitt NN; Wake DJ; Forbes S; Stimson RH; Gibb FW
    Diabet Med; 2021 Jan; 38(1):e14374. PubMed ID: 32740984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.